InvestorsHub Logo
Followers 0
Posts 2165
Boards Moderated 0
Alias Born 03/19/2015

Re: None

Thursday, 03/31/2016 11:40:56 AM

Thursday, March 31, 2016 11:40:56 AM

Post# of 39191
I'm hoping for the potential of the revenue to be understood LOOOOOONG before actual revenue is actually calculated on some quarterly report. For the purposes of affecting stock price, the general investing public just needs to have an idea of their stocks potential to want to buy in at higher and higher prices. The product is not even on a store shelf yet, testing will take two more months, placement could take a while, and it will take a minute for general public to learn of the brand name. NO, I am NOT waiting for revenue to see pps rise, that will take another year, in which case I might as well not even look at the stock right now. Rather I'm hoping that excitement created around early buzz regarding Emesyl develops LOOOOONG before sales numbers are available. I'm not here hoping that Itonis is a success, I'm here that ITNS STOCK is a success, and the success of one doesn't always correlate to the other.
Sometimes great companies with great products have poor stock performance due to manipulation or bad timing, or just bad luck. Other times crap companies get amazing stock pps rise just due to hype. Shareholders need to understand that all that affects their investment, is public impression, not sales figures. For a shareholder to publicly emphasize importance of revenue before revenue has arrived, I believe is a big mistake. Imo.